참고문헌
- Poole-Wilson PA. Measurement of myocardial intracellular pH in pathological states. J Mol Cell Cardiol. 1978;10:511-526. https://doi.org/10.1016/0022-2828(78)90010-X
- Reichert M, Steinbach JP, Supra P, Weller M. Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis. Cancer. 2002;95:1113-1119. https://doi.org/10.1002/cncr.10767
- Thews O, Gassner B, Kelleher DK, Schwerdt G, Gekle M. Impact of hypoxic and acidic extracellular conditions on cytotoxicity of chemotherapeutic drugs. Adv Exp Med Biol. 2007;599:155-161.
- Wilting RH, Dannenberg JH. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. Drug Resist Updat. 2012;15:21-38. https://doi.org/10.1016/j.drup.2012.01.008
- Raghunand N, Gillies RJ. pH and drug resistance in tumors. Drug Resist Updat. 2000;3:39-47. https://doi.org/10.1054/drup.2000.0119
-
Fais S, De Milito A, You H, Qin W. Targeting vacuolar
$H^{2+}$ -ATPases as a new strategy against cancer. Cancer Res. 2007;67:10627-10630. https://doi.org/10.1158/0008-5472.CAN-07-1805 - Taylor S, Spugnini EP, Assaraf YG, Azzarito T, Rauch C, Fais S. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach. Drug Resist Updat. 2015;23:69-78. https://doi.org/10.1016/j.drup.2015.08.004
- Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009;125:666-673. https://doi.org/10.1002/ijc.24290
- Peleteiro B, Severo M, La Vecchia C, Lunet N. Model-based patterns in stomach cancer mortality worldwide. Eur J Cancer Prev. 2014;23:524-531. https://doi.org/10.1097/CEJ.0b013e328364f2b6
- Deng K, Lin S, Zhou L, Li Y, Chen M, Wang Y, Li Y. High levels of aromatic amino acids in gastric juice during the early stages of gastric cancer progression. PLoS One. 2012;7:e49434. https://doi.org/10.1371/journal.pone.0049434
- Estrella V, Chen T, Lloyd M, Wojtkowiak J, Cornnell HH, Ibrahim-Hashim A, Bailey K, Balagurunathan Y, Rothberg JM, Sloane BF, Johnson J, Gatenby RA, Gillies RJ. Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 2013;73:1524-1535. https://doi.org/10.1158/0008-5472.CAN-12-2796
- Wang S. The promise of cancer therapeutics targeting the TNFrelated apoptosis-inducing ligand and TRAIL receptor pathway. Oncogene. 2008;27:6207-6215. https://doi.org/10.1038/onc.2008.298
- Gura T. How TRAIL kills cancer cells, but not normal cells. Science. 1997;277:768. https://doi.org/10.1126/science.277.5327.768
- Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999;5:157-163. https://doi.org/10.1038/5517
- Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. J Immunol. 1999;163:5358-5366.
- Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene. 1998;17:3261-3270. https://doi.org/10.1038/sj.onc.1202568
- Shin JN, Park SY, Cha JH, Park JY, Lee BR, Jung SA, Lee ST, Yun CW, Seol DW, Kim TH. Generation of a novel proform of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein that can be reactivated by matrix metalloproteinases. Exp Cell Res. 2006;312:3892-3898. https://doi.org/10.1016/j.yexcr.2006.08.015
- Lim SC, Choi JE, Kang HS, Han SI. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma. Int J Cancer. 2010;126:1582-1595.
- Luo S, Rubinsztein DC. Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ. 2007;14:1247-1250. https://doi.org/10.1038/sj.cdd.4402149
- Apel A, Herr I, Schwarz H, Rodemann HP, Mayer A. Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res. 2008;68:1485-1494. https://doi.org/10.1158/0008-5472.CAN-07-0562
- Han W, Sun J, Feng L, Wang K, Li D, Pan Q, Chen Y, Jin W, Wang X, Pan H, Jin H. Autophagy inhibition enhances daunorubicininduced apoptosis in K562 cells. PLoS One. 2011;6:e28491. https://doi.org/10.1371/journal.pone.0028491
- Buzzard KA, Giaccia AJ, Killender M, Anderson RL. Heat shock protein 72 modulates pathways of stress-induced apoptosis. J Biol Chem. 1998;273:17147-17153. https://doi.org/10.1074/jbc.273.27.17147
- Su C, Su B, Tang L, Zhao Y, Zhou C. Effects of collagen iv on cisplatin-induced apoptosis of non-small cell lung cancer cells. Cancer Invest. 2007;25:542-549. https://doi.org/10.1080/07357900701513272
- Januchowski R, Swierczewska M, Sterzynska K, Wojtowicz K, Nowicki M, Zabel M. Increased expression of several collagen genes is associated with drug resistance in ovarian cancer cell lines. J Cancer. 2016;7:1295-1310. https://doi.org/10.7150/jca.15371
- Vukovic V, Tannock IF. Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan. Br J Cancer. 1997;75:1167-1172. https://doi.org/10.1038/bjc.1997.201
- Wachsberger PR, Landry J, Storck C, Davis K, O'Hara MD, Owen CS, Leeper DB, Coss RA. Mammalian cells adapted to growth at pH 6.7 have elevated HSP27 levels and are resistant to cisplatin. Int J Hyperthermia. 1997;13:251-255; discussion 257-9. https://doi.org/10.3109/02656739709023533
- Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snailinduced EMT of cancer cells. Cancer Cell. 2009;15:195-206. https://doi.org/10.1016/j.ccr.2009.01.023
- Tan X, Banerjee P, Liu X, Yu J, Gibbons DL, Wu P, Scott KL, Diao L, Zheng X, Wang J, Jalali A, Suraokar M, Fujimoto J, Behrens C, Liu X, Liu CG, Creighton CJ, Wistuba II, Kurie JM. The epithelialto-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network. J Clin Invest. 2018;128:1267-1282. https://doi.org/10.1172/JCI97225
- Hardy J, Jones A, Gore ME, Viner C, Selby P, Wiltshaw E. Treatment of advanced ovarian cancer with intraperitoneal tumour necrosis factor. Eur J Cancer. 1990;26:771. https://doi.org/10.1016/0277-5379(90)90146-K
- Barnhart BC, Legembre P, Pietras E, Bubici C, Franzoso G, Peter ME. CD95 ligand induces motility and invasiveness of apoptosisresistant tumor cells. EMBO J. 2004;23:3175-3185. https://doi.org/10.1038/sj.emboj.7600325
- Srivastava RK. TRAIL/Apo-2L: mechanisms and clinical applications in cancer. Neoplasia. 2001;3:535-546. https://doi.org/10.1038/sj.neo.7900203
- Lemke J, von Karstedt S, Zinngrebe J, Walczak H. Getting TRAIL back on track for cancer therapy. Cell Death Differ. 2014;21:1350-1364. https://doi.org/10.1038/cdd.2014.81
- Lim SC, Parajuli KR, Han SI. The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway. Tumour Biol. 2016;37:6205-6216. https://doi.org/10.1007/s13277-015-4485-9
- Jin CY, Park C, Cheong J, Choi BT, Lee TH, Lee JD, Lee WH, Kim GY, Ryu CH, Choi YH. Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3. Cancer Lett. 2007;257:56-64. https://doi.org/10.1016/j.canlet.2007.06.019
- Jung EM, Park JW, Choi KS, Park JW, Lee HI, Lee KS, Kwon TK. Curcumin sensitizes tumor necrosis factor-related apoptosisinducing ligand (TRAIL)-mediated apoptosis through CHOPindependent DR5 upregulation. Carcinogenesis. 2006;27:2008-2017. https://doi.org/10.1093/carcin/bgl026
- Yoon MJ, Kang YJ, Kim IY, Kim EH, Lee JA, Lim JH, Kwon TK, Choi KS. Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation. Carcinogenesis. 2013;34:1918-1928. https://doi.org/10.1093/carcin/bgt137
- Huang Y, Yang X, Xu T, Kong Q, Zhang Y, Shen Y, Wei Y, Wang G, Chang KJ. Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs. Int J Oncol. 2016;49:153-163. https://doi.org/10.3892/ijo.2016.3525
- Lee YJ, Song JJ, Kim JH, Kim HR, Song YK. Low extracellular pH augments TRAIL-induced apoptotic death through the mitochondria-mediated caspase signal transduction pathway. Exp Cell Res. 2004;293:129-143. https://doi.org/10.1016/j.yexcr.2003.09.015
피인용 문헌
- Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells vol.19, pp.11, 2018, https://doi.org/10.3390/ijms19113424
- Phenotypic transition of tumor cells between epithelial- and mesenchymal-like state during adaptation to acidosis vol.18, pp.16, 2018, https://doi.org/10.1080/15384101.2019.1635868
- Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy vol.10, pp.None, 2018, https://doi.org/10.3389/fimmu.2019.01530
- Alteration and dysfunction of ion channels/transporters in a hypoxic microenvironment results in the development and progression of gastric cancer vol.44, pp.4, 2018, https://doi.org/10.1007/s13402-021-00604-1